共 50 条
- [1] The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis [J]. JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
- [2] Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy [J]. World Journal of Surgical Oncology, 21
- [5] Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin [J]. International Journal of Clinical Oncology, 2018, 23 : 298 - 304